{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T17:27:01Z","timestamp":1778261221298,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T00:00:00Z","timestamp":1666569600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["175083"],"award-info":[{"award-number":["175083"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s13760-022-02121-w","type":"journal-article","created":{"date-parts":[[2022,10,24]],"date-time":"2022-10-24T04:02:50Z","timestamp":1666584170000},"page":"529-536","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["COVID-19 infection and vaccination against SARS-CoV-2 in myasthenia gravis"],"prefix":"10.1007","volume":"123","author":[{"given":"Stojan","family":"Peric","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milos","family":"Rankovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6623-0779","authenticated-orcid":false,"given":"Ivo","family":"Bozovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanja","family":"Radosavljevic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan","family":"Marjanovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Basta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dragana","family":"Lavrnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,24]]},"reference":[{"issue":"11","key":"2121_CR1","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1172\/JCI29894","volume":"116","author":"BM Conti-Fine","year":"2006","unstructured":"Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, and future. J Clin Invest 116(11):2843\u20132854. https:\/\/doi.org\/10.1172\/JCI29894","journal-title":"J Clin Invest"},{"issue":"3","key":"2121_CR2","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s13760-018-0915-y","volume":"118","author":"M Stankovic","year":"2018","unstructured":"Stankovic M, Peric S, Stojiljkovic Tamas O, Stankovic T, Nikolic A, Lavrnic D et al (2018) Quality of life in patients with MuSK positive myasthenia gravis. Acta Neurol Belg 118(3):423\u2013427. https:\/\/doi.org\/10.1007\/s13760-018-0915-y","journal-title":"Acta Neurol Belg"},{"issue":"6","key":"2121_CR3","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1007\/s10072-012-1170-2","volume":"33","author":"I Basta","year":"2012","unstructured":"Basta I, Pekmezovic T, Peric S, Kisic-Tepavcevic D, Rakocevic-Stojanovic V, Stevic Z et al (2012) Assessment of health-related quality of life in patients with myasthenia gravis in Belgrade (Serbia). Neurol Sci 33(6):1375\u20131381. https:\/\/doi.org\/10.1007\/s10072-012-1170-2","journal-title":"Neurol Sci"},{"issue":"2","key":"2121_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mus.20950","volume":"37","author":"D Grob","year":"2008","unstructured":"Grob D, Brunner N, Namba T, Pagala M (2008) Lifetime course of myasthenia gravis. Muscle Nerve 37(2):141\u2013149. https:\/\/doi.org\/10.1002\/mus.20950","journal-title":"Muscle Nerve"},{"issue":"2","key":"2121_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5603\/CJ.a2020.0065","volume":"27","author":"MM Kowalik","year":"2020","unstructured":"Kowalik MM, Trzonkowski P, \u0141asi\u0144ska-Kowara M, Mital A, Smiatacz T, Jaguszewski M (2020) COVID-19\u2014toward a comprehensive understanding of the disease. Cardiol J 27(2):99\u2013114. https:\/\/doi.org\/10.5603\/CJ.a2020.0065","journal-title":"Cardiol J"},{"issue":"8","key":"2121_CR6","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/v11080762","volume":"11","author":"MK Smatti","year":"2019","unstructured":"Smatti MK, Cyprian FS, Nasrallah GK, Al Thani AA, Almishal RO, Yassine HM (2019) Viruses and autoimmunity: a review on the potential interaction and molecular mechanisms. Viruses 11(8):762. https:\/\/doi.org\/10.3390\/v11080762","journal-title":"Viruses"},{"issue":"6","key":"2121_CR7","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1007\/s00415-018-8751-9","volume":"265","author":"NE Gilhus","year":"2018","unstructured":"Gilhus NE, Romi F, Hong Y, Skeie GO (2018) Myasthenia gravis and infectious disease. J Neurol 265(6):1251\u20131258. https:\/\/doi.org\/10.1007\/s00415-018-8751-9","journal-title":"J Neurol"},{"key":"2121_CR8","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1007\/s00415-021-10759-4","volume":"269","author":"I Bozovic","year":"2022","unstructured":"Bozovic I, Ilic Zivojinovic J, Peric S et al (2022) Long-term outcome in patients with myasthenia gravis: one decade longitudinal study. J Neurol 269:2039\u20132045. https:\/\/doi.org\/10.1007\/s00415-021-10759-4","journal-title":"J Neurol"},{"issue":"2","key":"2121_CR9","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/mus.27324","volume":"64","author":"P Businaro","year":"2021","unstructured":"Businaro P, Vaghi G, Marchioni E, Diamanti L, Arceri S, Bini P et al (2021) COVID-19 in patients with myasthenia gravis: epidemiology and disease course. Muscle Nerve 64(2):206\u2013211. https:\/\/doi.org\/10.1002\/mus.27324","journal-title":"Muscle Nerve"},{"issue":"7","key":"2121_CR10","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1002\/jmv.26501","volume":"93","author":"J Finsterer","year":"2021","unstructured":"Finsterer J, Scorza FA, Scorza CA, Fiorini AC (2021) SARS-CoV-2 and myasthenia. J Med Virol 93(7):4133\u20134135. https:\/\/doi.org\/10.1002\/jmv.26501","journal-title":"J Med Virol"},{"key":"2121_CR11","unstructured":"MGFA. MGFA Official Statement on the COVID-19 Vaccine for the MG Community; Available from: https:\/\/myasthenia.org\/MG-Community\/COVID-19-Resource-Center (Accessed February 2022)."},{"key":"2121_CR12","unstructured":"CDC. Considerations for COVID-19 vaccination in moderately or severely immunocompromised people; Available from: https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html#considerations-covid19-vax-immunocopromised (Accessed February 2022)."},{"issue":"8","key":"2121_CR13","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.3390\/jcm10081736","volume":"10","author":"RT Rousseff","year":"2021","unstructured":"Rousseff RT (2021) Diagnosis of myasthenia gravis. J Clin Med 10(8):1736. https:\/\/doi.org\/10.3390\/jcm10081736","journal-title":"J Clin Med"},{"key":"2121_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2012\/874680","volume":"2012","author":"A JayamTrouth","year":"2012","unstructured":"JayamTrouth A, Dabi A, Solieman N, Kurukumbi M, Kalyanam J (2012) Myasthenia gravis: a review. Autoimmune dis 2012:1\u201310. https:\/\/doi.org\/10.1155\/2012\/874680","journal-title":"Autoimmune dis"},{"issue":"8","key":"2121_CR15","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/S1473-3099(20)30483-7","volume":"20","author":"JC Marshall","year":"2020","unstructured":"Marshall JC, Murthy S, Diaz J, Adhikari NK, Angus DC, Arabi YM et al (2020) A minimal common outcome measure set for COVID-19 clinical research. Lancet Infect Dis 20(8):192\u2013197. https:\/\/doi.org\/10.1016\/S1473-3099(20)30483-7","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"2121_CR16","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mus.22140","volume":"44","author":"S Muppidi","year":"2011","unstructured":"Muppidi S, Wolfe GI, Conaway M, Burns TM (2011) MG-ADL: still a relevant outcome measure. Muscle Nerve 44(5):727\u2013731. https:\/\/doi.org\/10.1002\/mus.22140","journal-title":"Muscle Nerve"},{"key":"2121_CR17","unstructured":"WHO. Serbia: WHO Coronavirus Disease (COVID-19) Dashboard with Vaccination Data. Available from: https:\/\/covid19.who.int\/region\/euro\/country\/rs (Accessed February 2022)."},{"issue":"1","key":"2121_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5603\/PJNNS.a2021.0054","volume":"56","author":"\u0141 Rzepi\u0144ski","year":"2021","unstructured":"Rzepi\u0144ski \u0141, Zawadka-Kunikowska M (2021) COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study. Neurol Neurochir Pol 56(1):61\u201367. https:\/\/doi.org\/10.5603\/PJNNS.a2021.0054","journal-title":"Neurol Neurochir Pol"},{"issue":"4","key":"2121_CR19","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/mus.27497","volume":"65","author":"O GungorTuncer","year":"2022","unstructured":"GungorTuncer O, Deymeer F (2022) Clinical course and outcome of an outpatient clinic population with myasthenia gravis and COVID-19. Muscle Nerve 65(4):447\u2013452. https:\/\/doi.org\/10.1002\/mus.27497","journal-title":"Muscle Nerve"},{"issue":"16","key":"2121_CR20","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1212\/WNL.0000000000011669","volume":"96","author":"G Sol\u00e9","year":"2021","unstructured":"Sol\u00e9 G, Mathis S, Friedman D, Salort-Campana E, Tard C, Bouhour F et al (2021) Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis. Neurology 96(16):2109\u20132120. https:\/\/doi.org\/10.1212\/WNL.0000000000011669","journal-title":"Neurology"},{"key":"2121_CR21","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1136\/bmj.m1198","volume":"368","author":"RE Jordan","year":"2020","unstructured":"Jordan RE, Adab P, Cheng K (2020) COVID-19: risk factors for severe disease and death. BMJ 368:1198. https:\/\/doi.org\/10.1136\/bmj.m1198","journal-title":"BMJ"},{"key":"2121_CR22","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3390\/neurolint14020033","volume":"14","author":"A Lupica","year":"2022","unstructured":"Lupica A, Di Stefano V, Iacono S et al (2022) Impact of COVID-19 in AChR myasthenia gravis and the safety of vaccines: data from an Italian cohort. Neurol Int 14:406\u2013416. https:\/\/doi.org\/10.3390\/neurolint14020033","journal-title":"Neurol Int"},{"issue":"10","key":"2121_CR23","doi-asserted-by":"publisher","first-page":"3418","DOI":"10.1111\/ene","volume":"28","author":"M Jakubikova","year":"2021","unstructured":"Jakubikova M, T\u00fdblov\u00e1 M, Tesa\u0159 A, Hor\u00e1kov\u00e1 M, Vla\u017en\u00e1 D, Ry\u0161\u00e1nkov\u00e1 I et al (2021) Predictive factors for a severe course of COVID-19 infection in myasthenia gravis patients with an overall impact on myasthenic outcome status and survival. Eur J Neurol 28(10):3418\u20133425. https:\/\/doi.org\/10.1111\/ene","journal-title":"Eur J Neurol"},{"issue":"4","key":"2121_CR24","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s13760-021-01662-w","volume":"121","author":"S \u017dupani\u0107","year":"2021","unstructured":"\u017dupani\u0107 S, Peri\u0107\u0160itum M, Majdak M, Karaka\u0161 M, Ba\u0161i\u0107 S, Spori\u0161 D (2021) Case series of COVID-19 in patients with myasthenia gravis: a single institution experience. Acta Neurol Belg 121(4):1039\u20131044. https:\/\/doi.org\/10.1007\/s13760-021-01662-w","journal-title":"Acta Neurol Belg"},{"issue":"4","key":"2121_CR25","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1007\/s10072-021-05823-w","volume":"43","author":"CL Rodrigues","year":"2022","unstructured":"Rodrigues CL, de Freitas HC, Lima PR, de Oliveira Junior PH, Fernandes JM, D\u2019Almeida JA et al (2022) Myasthenia gravis exacerbation and myasthenic crisis associated with COVID-19: case series and literature review. Neurol Sci 43(4):2271\u20132276. https:\/\/doi.org\/10.1007\/s10072-021-05823-w","journal-title":"Neurol Sci"},{"key":"2121_CR26","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","volume":"11","author":"AE Camelo-Filho","year":"2020","unstructured":"Camelo-Filho AE, Silva A, Estephan EP, Zambon AA, Mendon\u00e7a RH, Souza PV et al (2020) Myasthenia gravis and COVID-19: clinical characteristics and outcomes. Front Neurol 11:1053. https:\/\/doi.org\/10.3389\/fneur.2020.01053","journal-title":"Front Neurol"},{"issue":"11","key":"2121_CR27","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/cid\/ciab408","volume":"73","author":"JL Hirschtick","year":"2021","unstructured":"Hirschtick JL, Titus AR, Slocum E, Power LE, Hirschtick RE, Elliott MR et al (2021) Population-based estimates of post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC) prevalence and characteristics. Clin Infect Dis 73(11):2055\u20132064. https:\/\/doi.org\/10.1093\/cid\/ciab408","journal-title":"Clin Infect Dis"},{"key":"2121_CR28","unstructured":"Our World in Data. Coronavirus (COVID-19) Vaccinations. Available from: https:\/\/ourworldindata.org\/covid-vaccinations (Accessed February 2022)"},{"key":"2121_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.733418","volume":"12","author":"Q Zhou","year":"2021","unstructured":"Zhou Q, Zhou R, Yang H, Yang H (2021) To be or not to be vaccinated: that is a question in myasthenia gravis. Front Immunol 12:733418. https:\/\/doi.org\/10.3389\/fimmu.2021.733418","journal-title":"Front Immunol"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-02121-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-022-02121-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-022-02121-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T03:53:29Z","timestamp":1682567609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13760-022-02121-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,24]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["2121"],"URL":"https:\/\/doi.org\/10.1007\/s13760-022-02121-w","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,24]]},"assertion":[{"value":"2 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This research was approved by the Ethical Board of the Neurology Clinic, University Clinical Center of Serbia.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Each author has read and approved the final manuscript version for submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}